Dosing Information
The FDA-approved dosage range for atorvastatin is 10 mg to 80 mg once daily 2. This applies to:
- Adults with primary hyperlipidemia and cardiovascular disease prevention 2
- Pediatric patients aged 10 years and older with homozygous familial hypercholesterolemia (HoFH) 2
For pediatric patients with heterozygous familial hypercholesterolemia (HeFH), the maximum dose is lower at 20 mg daily 2.
High-Intensity Statin Therapy
Atorvastatin 40-80 mg constitutes high-intensity statin therapy, which achieves ≥50% reduction in LDL cholesterol 3, 4, 3. Current guidelines recommend:
- Atorvastatin 80 mg for patients with established atherosclerotic cardiovascular disease (secondary prevention) 4, 5, 6
- Atorvastatin 40-80 mg for very high-risk patients requiring aggressive LDL-C lowering 3, 7
The 2024 ESC guidelines specifically recommend "high-intensity statin up to the highest tolerated dose" for patients with chronic coronary syndrome 7.
Important Dosing Considerations
Drug Interactions Requiring Dose Limitation
Do not exceed atorvastatin 20 mg daily when taking 2:
- Clarithromycin or itraconazole
- Saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir (with or without ritonavir)
- Elbasvir plus grazoprevir or letermovir
Do not exceed atorvastatin 40 mg daily when taking nelfinavir 2.
Administration Details
- Can be taken at any time of day, with or without food 2
- Assess LDL-C as early as 4 weeks after initiation and adjust dosage accordingly 2
- If a dose is missed, skip it and resume with the next scheduled dose 2
Safety Profile at Maximum Dose
The 80 mg dose has been extensively studied and shown to be generally well-tolerated 8. A pooled analysis of 4,798 patients on atorvastatin 80 mg showed similar adverse event rates compared to 10 mg, with persistent hepatic transaminase elevations >3× ULN occurring in only 0.6% of patients 8. However, real-world data suggests physicians remain reluctant to prescribe the maximum dose, with only 4.8% of high-risk patients receiving 80 mg in one study 9.
Common pitfall: Many clinicians undertreated patients by not using guideline-recommended high-intensity doses, with studies showing only 36-49% of appropriate patients receiving recommended statin intensity 10, 9, 11.